Related Experiment Video
Updated: Feb 11, 2026

Three-dimensional Alginate-bead Culture of Human Pituitary Adenoma Cells
Published on: February 18, 2016
The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
Peng-Fei Wang1, Ting-Jian Wang1, Ya-Kun Yang1
1Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Background:
Pituitary adenomas (PAs) are the second most common brain tumors, and mostly are benign tumors. However, there exists subtypes of PAs refractory to common treatments, and need novel therapy. Programmed death 1 (PD-1) blockade has shown durable objective response in a variety of malignancies, and the key predictive markers for this immunotherapy were PD-L1 and CD8+ tumor-infiltrating lymphocyte (TILs) expression. To evaluate the potential immunotherapy for PAs, we investigated the expression of these two immune markers in PAs.
Methods:
Immunohistochemistry (IHC) was performed to detect the expression of PD-L1 and CD8+ TILs in PAs. The ratio of positive expression of PD-L1 and CD8+ TILs was compared with chi-squared tests among different subtypes of PAs. The association between their expression profile and clinical parameters was analyzed using a chi-squared test, or Fisher's exact probability test when appropriate.
Results:
One hundred and ninety one patients with PAs were retrospectively involved in this study, consisting of 106 non-functioning PAs (NF-PAs, 55.5%), 40 PRL-secreting PAs (PRL-PAs, 20.9%), 31 GH-secreting PAs (GH-PAs, 16.2%), 9 ACTH-secreting PAs (ACTH-PAs, 4.7%) and 5 plurihormonal adenomas (2.6%) respectively. 36.6% of them were PD-L1 positive and 86.9% were CD8+ TILs positive. The positive PD-L1 immunostaining presented more frequently in functioning PAs (58.8%), compared with that (34.3%) in nonfunctioning group (p = 0.000). Moreover, the rates of PD-L1 expression were more associated with increased blood levels of PRL, GH, ACTH and cortisol. Contrastly, positive CD8+ TILs immunostaining was only correlated with elevated blood level of GH. For the analysis of immune markers with pathological results, PD-L1 expression was associated with PRL and GH immunostaining and higher Ki-67 index. But CD8+ TILs was only correlated with PRL immunostaining.
Conclusion:
Our results showed that PD-L1 was frequently expressed in functioning PAs with association of aggressive behaviors in PAs. The immunotherapy could be a promising treatment option of PAs.
Insights
Programmed death-ligand 1 (PD-L1) and CD8+ tumor-infiltrating lymphocytes (TILs) were investigated in pituitary adenomas (PAs). PD-L1 was frequently expressed in functioning PAs, suggesting immunotherapy potential for PAs.
Area of Science:
- Neuro-oncology
- Immunology
- Endocrinology
Background:
- Pituitary adenomas (PAs) are common brain tumors, with some subtypes resistant to standard treatments.
- Novel therapeutic strategies are needed for treatment-refractory PAs.
- Programmed death 1 (PD-1) blockade shows promise in various cancers, with PD-L1 and CD8+ tumor-infiltrating lymphocyte (TILs) as predictive markers.
Purpose of the Study:
- To investigate the expression of PD-L1 and CD8+ TILs in PAs.
- To evaluate the potential of immunotherapy for pituitary adenomas.
Main Methods:
- Immunohistochemistry (IHC) was used to detect PD-L1 and CD8+ TIL expression in 191 PAs.
- Statistical analyses (chi-squared tests, Fisher's exact test) compared marker expression across PA subtypes and clinical parameters.
Main Results:
- PD-L1 was positive in 36.6% and CD8+ TILs in 86.9% of PAs.
- PD-L1 expression was significantly higher in functioning PAs (58.8%) versus non-functioning PAs (34.3%).
- PD-L1 expression correlated with PRL, GH, ACTH, cortisol levels, PRL/GH immunostaining, and higher Ki-67 index; CD8+ TILs correlated with GH levels and PRL immunostaining.
Conclusions:
- PD-L1 is frequently expressed in functioning PAs and associated with aggressive features.
- These findings suggest that PD-1 blockade immunotherapy could be a viable treatment option for PAs.
Related Concept Videos
Hypothalamic-Pituitary Axis
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Tumor Immunotherapy
The Pituitary Gland
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...

